Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Auteur de référence en rhumatologie
28 articles scientifiques publiés — un praticien à la pointe de la recherche
Délais de RDV courts dans la région
97.1 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
74
74 articles ont été cités au moins 74fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
20 751
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
662
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
328
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Biologie et Génétique des Interactions Plante-Parasite
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Comparison of the immunological and virological responses to cART between HIV-1/O and HIV-1/M patients followed up in France
2025ArticleJournal of Antimicrobial Chemotherapy
Salvage Therapy Including Foscarnet and Ibalizumab for Multidrug-Resistant Human Immunodeficiency Virus Type 2 Infection
2024ArticleClinical Infectious Diseases
A highly virulent variant of HIV-1 circulating in the Netherlands
2022ArticleScience
Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence Prophylaxis makes the difference
2019ArticleJournal of Hepatology
Immunotherapy for cancer in people living with HIV: safety with an efficacy signal from the series in real life experience
2019ArticleAIDS. Official journal of the international AIDS Society
12 weeks of a Ribavirin-free Sofosbuvir and NS5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation
2018ArticleHepatology
Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study
2017ArticleAmerican Journal of Transplantation
Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort
2017ArticleJournal of Acquired Immune Deficiency Syndromes - JAIDS
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
CHD SITE LA ROCHE SUR YON
LES OUDAIRIES BD STEPHANE MOREAU, 85925 LA ROCHE SUR YON CEDEX 9
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2022
Background West Nile virus (WNV) and Usutu virus (USUV), two closely related flaviviruses, mainly follow an enzootic cycle involving mosquitoes and birds, but also infect humans and other mammals. Since 2010, their epidemiological situation may have shifted from irregular epidemics to endemicity in several European regions; this requires confirmation, as it could have implications for risk assessment and surveillance strategies. Aim To explore the seroprevalence in animals and humans and potential endemicity of WNV and USUV in Southern France, given a long history of WNV outbreaks and the only severe human USUV case in France in this region. Methods We evaluated the prevalence of WNV and USUV in a repeated cross-sectional study by serological and molecular analyses of human, dog, horse, bird and mosquito samples in the Camargue area, including the city of Montpellier, between 2016 and 2020. Results We observed the active transmission of both viruses and higher USUV prevalence in humans, dogs, birds and mosquitoes, while WNV prevalence was higher in horses. In 500 human samples, 15 were positive for USUV and 6 for WNV. Genetic data showed that the same lineages, WNV lineage 1a and USUV lineage Africa 3, were found in mosquitoes in 2015, 2018 and 2020. Conclusion These findings support existing literature suggesting endemisation in the study region and contribute to a better understanding of USUV and WNV circulation in Southern France. Our study underlines the importance of a One Health approach for the surveillance of these viruses.
Journal of medical virology · 2024
Abstract Mitochondria are vital for most cells' functions. Viruses hijack mitochondria machinery for misappropriation of energy supply or to bypass defense mechanisms. Many of these mitochondrial dysfunctions persist after recovery from treated or untreated viral infections, particularly when mitochondrial DNA is permanently damaged. Quantitative defects and structural rearrangements of mitochondrial DNA accumulate in post‐mitotic tissues as recently reported long after SARS‐CoV‐2 or HIV infection, or following antiviral therapy. These observations are consistent with the “hit‐and‐run” concept proposed decades ago to explain viro‐induced cell transformation and it could apply to delayed post‐viral onsets of symptoms and advocate for complementary supportive care. Thus, according to this concept, following exposure to viruses or antiviral agents, mitochondrial damage could evolve into an autonomous clinical condition. It also establishes a pathogenic link between communicable and non‐communicable chronic diseases.
Immunity, inflammation and disease · 2024
Key messages Passive immunoprophylaxis with broadly neutralizing monoclonal antibodies (bNAbs) could be a game changer in the prevention of human immunodeficiency virus (HIV) acquisition. The prevailing view is that available resources should be focused on identifying a fixed combination of at least three bNAbs for universal use in therapeutic and preventive protocols, regardless of target populations or routes of transmission. HIV transmission through breastfeeding is unique: it involves free viral particles and cell‐associated virus from breast milk and, in the case of acute/recent maternal infection, a viral population with restricted Env diversity. HIV transmission through breastfeeding in high incidence/prevalence areas could potentially be eliminated by subcutaneous administration to all newborns of one or two long‐acting bNAbs with extended breadth, high potency, and effector properties (ADCC, phagocytosis) against circulating HIV strains.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Paediatric drugs · 2026 · Journal Article
Van de Perre P, Meda N, Tassembedo S, Moles JP, et al.
The lancet. HIV · 2025 · Journal Article
Tassembedo S, Meda N, Kankasa C, Shapiro R, et al.
Journal of leukocyte biology · 2024 · Journal Article
Domitien Payet L, Bedin AS, Desselas É, Marie-Jeanne C, et al.
Lancet (London, England) · 2024 · Letter
Van de Perre P, Tylleskär T
Journal of medical virology · 2024 · Journal Article
Capelli N, Domitien Payet L, Alcocer Cordellat C, Pisoni A, et al.
Cells · 2023 · Journal Article
Dmitrenko B, Gatinois V, D'Ottavi M, El Mouatani A, et al.
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2022 · Letter
Van de Perre P, Molès JP, Rollins N
Biomedicines · 2022 · Journal Article
Desquiret-Dumas V, D'Ottavi M, Monnin A, Goudenège D, et al.
Bulletin of the World Health Organization · 2022 · Journal Article
Guingané AN, Kaboré R, Shimakawa Y, Somé EN, et al.
Health science reports · 2026 · Journal Article
Dmitrenko B, Vintejoux E, Fuchs F, Pissarra J, et al.
Immunity, inflammation and disease · 2024 · Journal Article
Van de Perre P, Scarlatti G, Moore PL, Molès JP, et al.
The American journal of tropical medicine and hygiene · 2024 · Journal Article
Zida S, Kania D, Bolloré K, Bandaogo O, et al.
Hepatology international · 2025 · Journal Article
Tran HT, Duong HT, Pham KM, Nguyen BT, et al.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025 · Journal Article
D'Ottavi M, Scialabba I, Huong DT, Giang HT, et al.
BMC women's health · 2025 · Journal Article
Delphine Sakana BL, Meda ZC, Ilboudo B, Ouattara A, et al.
The Lancet regional health. Western Pacific · 2022 · Journal Article
BMC public health · 2024 · Journal Article
Mennecier A, Matoka B, Wilfred-Tonga MM, Chunda-Liyoka C, et al.
Lancet (London, England) · 2024 · Randomized Controlled Trial
Kankasa C, Mennecier A, Sakana BLD, Molès JP, et al.
Expert review of anti-infective therapy · 2025 · Journal Article
Van de Perre P, Moles JP, Nagot N
Journal of medical virology · 2024 · Journal Article
Gay L, Desquiret-Dumas V, Nagot N, Rapenne C, et al.
The Journal of infectious diseases · 2022 · Published Erratum
Bedin AS, Makinson A, Picot MC, Mennechet F, et al.
BMC infectious diseases · 2024 · Clinical Trial Protocol
Goga A, Ramraj T, Naidoo L, Daniels B, et al.
Differential neurovirulence of Usutu virus lineages in mice and neuronal cells
Abstract Background Usutu virus (USUV) is an emerging neurotropic arthropod-borne virus recently involved in massive die offs of wild birds predominantly reported in Europe. Although primarily asymptomatic or presenting
Breastfeeding patterns and its determinants among mothers living with Human Immuno-deficiency Virus -1 in four African countries participating in the ANRS 12174 trial
Abstract Background HIV-1 transmission rates have been reduced over the last decade, an estimated 2 million new infections per year arise, including 220,000 paediatric cases. The main post-natal HIV exposure is through b
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).
The lancet. HIV · 2024 · Journal Article
Van de Perre P, Moore PL
Frontiers in public health · 2023 · Journal Article
Mennecier A, Matoka B, Wilfred-Tonga MM, Chunda-Liyoka C, et al.
Medicine · 2022 · Journal Article
Abraham P, Marin G, Filleron A, Michon AL, et al.
The Journal of infectious diseases · 2022 · Journal Article
Veyrenche N, Pisoni A, Debiesse S, Bollore K, et al.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2022 · Journal Article
Constant O, Gil P, Barthelemy J, Bolloré K, et al.
Duong HT, Moles JP, Pham KM, Vallo R, et al.
Frontiers in microbiology · 2022 · Journal Article
Carrère-Kremer S, Kolia-Diafouka P, Pisoni A, Bolloré K, et al.